View Author
Vrie, W. van de
(Wim van de Vrie)
tumor resistance cancer cyclosporin study level expression p-glycoprotein model multidrug doxorubicin dexniguldipine experiment effect tissue treatment patient group modulation multidrug resistance reverter drug resistance concentration reversal colon result plasma growth carcinoma chemosensitizer pastan i mechanism gottesman mm verapamil assay activity combination pglycoprotein table leukemia vivo model systems p-glycoprotein expression mouse cell lines animal chemotherapy difference van oosterom anticancer drugs control toxicity tumor cells anticancer barrett drug resistance mechanisms liver antibody rodent sensitivity trial eggermont daunorubicin cytotoxicity gottesman argon plasma coagulation eggermont amm blood ascite pharmacokinetic pastan addition administration system kidney cc 531 cells cell line ala-pdt enhancement efficacy murine
2 Most Recent Publications
|
5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial
(Article)
Hage, M. Siersema, P.D. Dekken, H. van Steyerberg, E.W. Haringsma, J. Vrie, W. van de Grool, T.E. Sterenborg, H.J.C.M. Kuipers, E.J. Veen, R.L.P. van |
2004-01-01
|
|
Modulation of P-glycoprotein-mediated multidrug resistance in the CC531 rat colon tumor model
(Doctoral Thesis)
Vrie, W. van de |
1997-04-09
|
